Overview

Clinical Trial in Patients With Metastatic Colorectal Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this trial is to compare efficacy and safety of CoFactor and 5-fluorouracil (5-FU) versus leucovorin and 5-FU in treatment of metastatic colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Mast Therapeutics, Inc.
Treatments:
Fluorouracil
Leucovorin